Market Tracker

06/26 4:45pm ET

Quest Diagnostics Inc (NYSE:DGX)

110.05
Delayed Data
As of 4:02pm ET
 +0.35 / +0.32%
Today’s Change
77.29
Today|||52-Week Range
110.65
+19.75%
Year-to-Date
Quest Diagnostics Enhances Blueprint for Athletes Service
9:52am / Zacks.com - Paid Partner Content
Why You Should Avoid Envision Healthcare (EVHC) Stock Now
Jun 15 / Zacks.com - Paid Partner Content
Quality Stocks in Gurus' Portfolios
Jun 23 / GuruFocus News - Paid Partner Content
Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space
Jun 13 / Zacks.com - Paid Partner Content
Why Quest Diagnostics (DGX) is a Suitable Pick for Investors
Jun 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close109.70
Today’s open109.74
Day’s range109.49 - 110.65
Volume805,182
Average volume (3 months)863,296
Market cap$15.0B
Dividend yield1.64%
Data as of 4:02pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)-7.16%
Earnings growth (this year)+8.10%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.29%
P/E ratio22.2
Price/Sales1.74
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
LHLaboratory Corporati...+0.68+0.45%
FMIFoundation Medicine ...-0.05-0.12%
GHDXGenomic Health Inc-0.16-0.48%
KANGiKang Healthcare Gro...-0.58-4.28%
Data as of 4:02pm ET, 06/26/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$7.5B
Annual profit (last year)$642.0M
Net profit margin8.54%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chairman, President &
Chief Executive Officer
Stephen H. Rusckowski
Chief Financial Officer &
Senior Vice President
Mark J. Guinan
Corporate headquarters
Madison, New Jersey

Forecasts